Description of cardioinhibition and arterial vasodepression in the response to carotid sinus massage
. | Pure CI n = 69 . | Pure aVD n = 23 . | CI and aVD n = 44 . | CI nor aVD n = 62 . | P-value (CI) . | P-value (aVD) . | P-value (CI × aVD) . |
---|---|---|---|---|---|---|---|
Age (years) | 65.0 ± 10.3 | 63.9 ± 11.4 | 63.4 ± 11.1 | 57.7 ± 13.2 | 0.029 | 0.088 | 0.014 |
M:F (n) | 38:31 | 13:10 | 30:14 | 32:30 | — | — | — |
SBP fall ≥ 50 mmHg (n) | 17 | 1 | 13 | 1a | — | — | — |
Asystole ≥ 3 s (n) | 8 | 0 | 6 | 0 | — | — | — |
Syncope last year (n; median IQR) | 1 (0–4) | 1 (0–1) | 1 (0–2) | 2 (0–4) | |||
Latencies | |||||||
T-min SBP | 16.0 ± 10.1 | 15.9 ± 10.7 | 14.4 ± 7.9 | 19.8 ± 13.0 | 0.044 | 0.22 | 0.74 |
T-min MAP | 14.0 ± 9.1 | 14.4 ± 8.5 | 12.0 ± 4.6 | 15.7 ± 11.2 | 0.10 | 0.39 | 0.57 |
T-min DBP | 13.7 ± 9.4 | 15.1 ± 8.7 | 13.8 ± 7.3 | 19.2 ± 3.2 | 0.0082 | 0.41 | 0.40 |
T-min HR | 7.3 ± 6.1 | 11.1 ± 9.2 | 7.5 ± 4.9 | 14.5 ± 14.0 | 0.0002 | 0.19 | 0.15 |
T-min TPR | 18.9 ± 10.3 | 18.8 ± 8.6 | 17.2 ± 5.7 | 17.6 ± 11.9 | 0.91 | 0.92 | 0.33 |
T-max SV | 10.6 ± 10.1 | 12.5 ± 6.7 | 10.9 ± 6.4 | 17.8 ± 12.7 | 0.013 | 0.16 | 0.12 |
Peak amplitudes | |||||||
Delta SBP | 35.0 ± 24.1 | 28.0 ± 16.6 | 39.4 ± 21.5 | 16.5 ± 13.8 | <0.0001 | 0.057 | 0.64 |
Delta MAP | 24.4 ± 16.5 | 20.1 ± 11.6 | 29.3 ± 15.5 | 10.2 ± 9.0 | <0.0001 | 0.0038 | 0.54 |
Delta DBP | 18.7 ± 12.5 | 16.7 ± 8.7 | 24.5 ± 12.5 | 8.1 ± 7.0 | <0.0001 | 0.0002 | 0.82 |
Delta HR | 25.2 ± 21.9 | 4.2 ± 4.0 | 23.4 ± 21.9 | 5.4 ± 5.8 | <0.0001 | 0.49 | 0.96 |
Delta TPR | 0.26 ± 0.33 | 0.40 ± 0.20 | 0.44 ± 0.23 | 0.13 ± 0.15 | 0.029 | <0.0001 | 0.20 |
Delta SV | 10.5 ± 10.5 | 11.6 ± 11.7 | 16.8 ± 12.2 | 4.8 ± 6.3 | 0.0012 | 0.0003 | 0.98 |
Sustained magnitude early period | |||||||
SusMagLR MAP | −43.2 ± 55.8 | −29.7 ± 31.1 | −58.1 + 58.6 | 1.1 + 34.8 | <0.0001 | 0.0071 | 0.49 |
SusMagLR HR | −42.6 ± 40.7 | 2.4 ± 30.6 | −34.5 + 27.7 | −1.3 + 22.6 | <0.0001 | 0.19 | 0.71 |
SusMagLR TPR | 1.9 ± 69.2 | −47.4 ± 44.6 | −53.8 + 51.9 | 15.0 + 50.9 | 0.62 | <0.0001 | 0.65 |
SusMagLR SV | −11.9 ± 62.9 | 23.0 ± 29.4 | 28.5 + 51.3 | −16.4 + 35.8 | 0.54 | <0.0001 | 0.73 |
Sustained magnitude late period | |||||||
Late SusMagLR MAP | −2.4 ± 40.7 | −4.8 ± 2.5 | −1.0 ± 27.1 | 2.3 ± 32.8 | 0.77 | 0.71 | 0.54 |
Late SusMagLR HR | −7.5 ± 28.6 | 27.1 ± 42.7 | −6.1 ± 34.9 | 7.2 ± 34.7 | <0.0001 | 0.066 | 0.11 |
Late SusMagLR TPR | 9.9 ± 69.8 | −25.7 ± 44.7 | −12.7 ± 61.8 | 14.4 ± 61.0 | 0.28 | 0.0036 | 0.37 |
Late SusMagLR SV | −13.3 ± 57.7 | −0.90 ± 22.5 | 12.4 ± 63.2 | −22.0 ± 53.1 | 0.31 | 0.021 | 0.67 |
. | Pure CI n = 69 . | Pure aVD n = 23 . | CI and aVD n = 44 . | CI nor aVD n = 62 . | P-value (CI) . | P-value (aVD) . | P-value (CI × aVD) . |
---|---|---|---|---|---|---|---|
Age (years) | 65.0 ± 10.3 | 63.9 ± 11.4 | 63.4 ± 11.1 | 57.7 ± 13.2 | 0.029 | 0.088 | 0.014 |
M:F (n) | 38:31 | 13:10 | 30:14 | 32:30 | — | — | — |
SBP fall ≥ 50 mmHg (n) | 17 | 1 | 13 | 1a | — | — | — |
Asystole ≥ 3 s (n) | 8 | 0 | 6 | 0 | — | — | — |
Syncope last year (n; median IQR) | 1 (0–4) | 1 (0–1) | 1 (0–2) | 2 (0–4) | |||
Latencies | |||||||
T-min SBP | 16.0 ± 10.1 | 15.9 ± 10.7 | 14.4 ± 7.9 | 19.8 ± 13.0 | 0.044 | 0.22 | 0.74 |
T-min MAP | 14.0 ± 9.1 | 14.4 ± 8.5 | 12.0 ± 4.6 | 15.7 ± 11.2 | 0.10 | 0.39 | 0.57 |
T-min DBP | 13.7 ± 9.4 | 15.1 ± 8.7 | 13.8 ± 7.3 | 19.2 ± 3.2 | 0.0082 | 0.41 | 0.40 |
T-min HR | 7.3 ± 6.1 | 11.1 ± 9.2 | 7.5 ± 4.9 | 14.5 ± 14.0 | 0.0002 | 0.19 | 0.15 |
T-min TPR | 18.9 ± 10.3 | 18.8 ± 8.6 | 17.2 ± 5.7 | 17.6 ± 11.9 | 0.91 | 0.92 | 0.33 |
T-max SV | 10.6 ± 10.1 | 12.5 ± 6.7 | 10.9 ± 6.4 | 17.8 ± 12.7 | 0.013 | 0.16 | 0.12 |
Peak amplitudes | |||||||
Delta SBP | 35.0 ± 24.1 | 28.0 ± 16.6 | 39.4 ± 21.5 | 16.5 ± 13.8 | <0.0001 | 0.057 | 0.64 |
Delta MAP | 24.4 ± 16.5 | 20.1 ± 11.6 | 29.3 ± 15.5 | 10.2 ± 9.0 | <0.0001 | 0.0038 | 0.54 |
Delta DBP | 18.7 ± 12.5 | 16.7 ± 8.7 | 24.5 ± 12.5 | 8.1 ± 7.0 | <0.0001 | 0.0002 | 0.82 |
Delta HR | 25.2 ± 21.9 | 4.2 ± 4.0 | 23.4 ± 21.9 | 5.4 ± 5.8 | <0.0001 | 0.49 | 0.96 |
Delta TPR | 0.26 ± 0.33 | 0.40 ± 0.20 | 0.44 ± 0.23 | 0.13 ± 0.15 | 0.029 | <0.0001 | 0.20 |
Delta SV | 10.5 ± 10.5 | 11.6 ± 11.7 | 16.8 ± 12.2 | 4.8 ± 6.3 | 0.0012 | 0.0003 | 0.98 |
Sustained magnitude early period | |||||||
SusMagLR MAP | −43.2 ± 55.8 | −29.7 ± 31.1 | −58.1 + 58.6 | 1.1 + 34.8 | <0.0001 | 0.0071 | 0.49 |
SusMagLR HR | −42.6 ± 40.7 | 2.4 ± 30.6 | −34.5 + 27.7 | −1.3 + 22.6 | <0.0001 | 0.19 | 0.71 |
SusMagLR TPR | 1.9 ± 69.2 | −47.4 ± 44.6 | −53.8 + 51.9 | 15.0 + 50.9 | 0.62 | <0.0001 | 0.65 |
SusMagLR SV | −11.9 ± 62.9 | 23.0 ± 29.4 | 28.5 + 51.3 | −16.4 + 35.8 | 0.54 | <0.0001 | 0.73 |
Sustained magnitude late period | |||||||
Late SusMagLR MAP | −2.4 ± 40.7 | −4.8 ± 2.5 | −1.0 ± 27.1 | 2.3 ± 32.8 | 0.77 | 0.71 | 0.54 |
Late SusMagLR HR | −7.5 ± 28.6 | 27.1 ± 42.7 | −6.1 ± 34.9 | 7.2 ± 34.7 | <0.0001 | 0.066 | 0.11 |
Late SusMagLR TPR | 9.9 ± 69.8 | −25.7 ± 44.7 | −12.7 ± 61.8 | 14.4 ± 61.0 | 0.28 | 0.0036 | 0.37 |
Late SusMagLR SV | −13.3 ± 57.7 | −0.90 ± 22.5 | 12.4 ± 63.2 | −22.0 ± 53.1 | 0.31 | 0.021 | 0.67 |
Local minima of HR and TPR were ‘overt’ when their amplitude was lower than 3 SD below the mean of baseline for SBP, MAP, HR, and TPR and higher for SV. Massages were divided into four combinations of presence or absence of overt peaks for HR and TPR: ‘pure CI’ means overt HR and obscure TPR; ‘overt aVD’ means obscure HR and overt TPR; ‘both CI and aVD’ means overt HR and overt TPR; and ‘CI nor aVD’ means obscure HR and obscure TPR. Logratio values are shown after multiplication by 1000 to help appreciate their relative sizes. P-values represent ANOVA with the factor CI (present or absent) and aVD (present of absent) and their interaction.
Delta, difference between period of interest and baseline period; SusMagLR, sustained magnitude in logratio units.
aThis case represents a combination of HR and TPR decreases that were 2.5 and 2.6 SD away from the mean, so neither reached the threshold to be recognized as CI or aVD.
Description of cardioinhibition and arterial vasodepression in the response to carotid sinus massage
. | Pure CI n = 69 . | Pure aVD n = 23 . | CI and aVD n = 44 . | CI nor aVD n = 62 . | P-value (CI) . | P-value (aVD) . | P-value (CI × aVD) . |
---|---|---|---|---|---|---|---|
Age (years) | 65.0 ± 10.3 | 63.9 ± 11.4 | 63.4 ± 11.1 | 57.7 ± 13.2 | 0.029 | 0.088 | 0.014 |
M:F (n) | 38:31 | 13:10 | 30:14 | 32:30 | — | — | — |
SBP fall ≥ 50 mmHg (n) | 17 | 1 | 13 | 1a | — | — | — |
Asystole ≥ 3 s (n) | 8 | 0 | 6 | 0 | — | — | — |
Syncope last year (n; median IQR) | 1 (0–4) | 1 (0–1) | 1 (0–2) | 2 (0–4) | |||
Latencies | |||||||
T-min SBP | 16.0 ± 10.1 | 15.9 ± 10.7 | 14.4 ± 7.9 | 19.8 ± 13.0 | 0.044 | 0.22 | 0.74 |
T-min MAP | 14.0 ± 9.1 | 14.4 ± 8.5 | 12.0 ± 4.6 | 15.7 ± 11.2 | 0.10 | 0.39 | 0.57 |
T-min DBP | 13.7 ± 9.4 | 15.1 ± 8.7 | 13.8 ± 7.3 | 19.2 ± 3.2 | 0.0082 | 0.41 | 0.40 |
T-min HR | 7.3 ± 6.1 | 11.1 ± 9.2 | 7.5 ± 4.9 | 14.5 ± 14.0 | 0.0002 | 0.19 | 0.15 |
T-min TPR | 18.9 ± 10.3 | 18.8 ± 8.6 | 17.2 ± 5.7 | 17.6 ± 11.9 | 0.91 | 0.92 | 0.33 |
T-max SV | 10.6 ± 10.1 | 12.5 ± 6.7 | 10.9 ± 6.4 | 17.8 ± 12.7 | 0.013 | 0.16 | 0.12 |
Peak amplitudes | |||||||
Delta SBP | 35.0 ± 24.1 | 28.0 ± 16.6 | 39.4 ± 21.5 | 16.5 ± 13.8 | <0.0001 | 0.057 | 0.64 |
Delta MAP | 24.4 ± 16.5 | 20.1 ± 11.6 | 29.3 ± 15.5 | 10.2 ± 9.0 | <0.0001 | 0.0038 | 0.54 |
Delta DBP | 18.7 ± 12.5 | 16.7 ± 8.7 | 24.5 ± 12.5 | 8.1 ± 7.0 | <0.0001 | 0.0002 | 0.82 |
Delta HR | 25.2 ± 21.9 | 4.2 ± 4.0 | 23.4 ± 21.9 | 5.4 ± 5.8 | <0.0001 | 0.49 | 0.96 |
Delta TPR | 0.26 ± 0.33 | 0.40 ± 0.20 | 0.44 ± 0.23 | 0.13 ± 0.15 | 0.029 | <0.0001 | 0.20 |
Delta SV | 10.5 ± 10.5 | 11.6 ± 11.7 | 16.8 ± 12.2 | 4.8 ± 6.3 | 0.0012 | 0.0003 | 0.98 |
Sustained magnitude early period | |||||||
SusMagLR MAP | −43.2 ± 55.8 | −29.7 ± 31.1 | −58.1 + 58.6 | 1.1 + 34.8 | <0.0001 | 0.0071 | 0.49 |
SusMagLR HR | −42.6 ± 40.7 | 2.4 ± 30.6 | −34.5 + 27.7 | −1.3 + 22.6 | <0.0001 | 0.19 | 0.71 |
SusMagLR TPR | 1.9 ± 69.2 | −47.4 ± 44.6 | −53.8 + 51.9 | 15.0 + 50.9 | 0.62 | <0.0001 | 0.65 |
SusMagLR SV | −11.9 ± 62.9 | 23.0 ± 29.4 | 28.5 + 51.3 | −16.4 + 35.8 | 0.54 | <0.0001 | 0.73 |
Sustained magnitude late period | |||||||
Late SusMagLR MAP | −2.4 ± 40.7 | −4.8 ± 2.5 | −1.0 ± 27.1 | 2.3 ± 32.8 | 0.77 | 0.71 | 0.54 |
Late SusMagLR HR | −7.5 ± 28.6 | 27.1 ± 42.7 | −6.1 ± 34.9 | 7.2 ± 34.7 | <0.0001 | 0.066 | 0.11 |
Late SusMagLR TPR | 9.9 ± 69.8 | −25.7 ± 44.7 | −12.7 ± 61.8 | 14.4 ± 61.0 | 0.28 | 0.0036 | 0.37 |
Late SusMagLR SV | −13.3 ± 57.7 | −0.90 ± 22.5 | 12.4 ± 63.2 | −22.0 ± 53.1 | 0.31 | 0.021 | 0.67 |
. | Pure CI n = 69 . | Pure aVD n = 23 . | CI and aVD n = 44 . | CI nor aVD n = 62 . | P-value (CI) . | P-value (aVD) . | P-value (CI × aVD) . |
---|---|---|---|---|---|---|---|
Age (years) | 65.0 ± 10.3 | 63.9 ± 11.4 | 63.4 ± 11.1 | 57.7 ± 13.2 | 0.029 | 0.088 | 0.014 |
M:F (n) | 38:31 | 13:10 | 30:14 | 32:30 | — | — | — |
SBP fall ≥ 50 mmHg (n) | 17 | 1 | 13 | 1a | — | — | — |
Asystole ≥ 3 s (n) | 8 | 0 | 6 | 0 | — | — | — |
Syncope last year (n; median IQR) | 1 (0–4) | 1 (0–1) | 1 (0–2) | 2 (0–4) | |||
Latencies | |||||||
T-min SBP | 16.0 ± 10.1 | 15.9 ± 10.7 | 14.4 ± 7.9 | 19.8 ± 13.0 | 0.044 | 0.22 | 0.74 |
T-min MAP | 14.0 ± 9.1 | 14.4 ± 8.5 | 12.0 ± 4.6 | 15.7 ± 11.2 | 0.10 | 0.39 | 0.57 |
T-min DBP | 13.7 ± 9.4 | 15.1 ± 8.7 | 13.8 ± 7.3 | 19.2 ± 3.2 | 0.0082 | 0.41 | 0.40 |
T-min HR | 7.3 ± 6.1 | 11.1 ± 9.2 | 7.5 ± 4.9 | 14.5 ± 14.0 | 0.0002 | 0.19 | 0.15 |
T-min TPR | 18.9 ± 10.3 | 18.8 ± 8.6 | 17.2 ± 5.7 | 17.6 ± 11.9 | 0.91 | 0.92 | 0.33 |
T-max SV | 10.6 ± 10.1 | 12.5 ± 6.7 | 10.9 ± 6.4 | 17.8 ± 12.7 | 0.013 | 0.16 | 0.12 |
Peak amplitudes | |||||||
Delta SBP | 35.0 ± 24.1 | 28.0 ± 16.6 | 39.4 ± 21.5 | 16.5 ± 13.8 | <0.0001 | 0.057 | 0.64 |
Delta MAP | 24.4 ± 16.5 | 20.1 ± 11.6 | 29.3 ± 15.5 | 10.2 ± 9.0 | <0.0001 | 0.0038 | 0.54 |
Delta DBP | 18.7 ± 12.5 | 16.7 ± 8.7 | 24.5 ± 12.5 | 8.1 ± 7.0 | <0.0001 | 0.0002 | 0.82 |
Delta HR | 25.2 ± 21.9 | 4.2 ± 4.0 | 23.4 ± 21.9 | 5.4 ± 5.8 | <0.0001 | 0.49 | 0.96 |
Delta TPR | 0.26 ± 0.33 | 0.40 ± 0.20 | 0.44 ± 0.23 | 0.13 ± 0.15 | 0.029 | <0.0001 | 0.20 |
Delta SV | 10.5 ± 10.5 | 11.6 ± 11.7 | 16.8 ± 12.2 | 4.8 ± 6.3 | 0.0012 | 0.0003 | 0.98 |
Sustained magnitude early period | |||||||
SusMagLR MAP | −43.2 ± 55.8 | −29.7 ± 31.1 | −58.1 + 58.6 | 1.1 + 34.8 | <0.0001 | 0.0071 | 0.49 |
SusMagLR HR | −42.6 ± 40.7 | 2.4 ± 30.6 | −34.5 + 27.7 | −1.3 + 22.6 | <0.0001 | 0.19 | 0.71 |
SusMagLR TPR | 1.9 ± 69.2 | −47.4 ± 44.6 | −53.8 + 51.9 | 15.0 + 50.9 | 0.62 | <0.0001 | 0.65 |
SusMagLR SV | −11.9 ± 62.9 | 23.0 ± 29.4 | 28.5 + 51.3 | −16.4 + 35.8 | 0.54 | <0.0001 | 0.73 |
Sustained magnitude late period | |||||||
Late SusMagLR MAP | −2.4 ± 40.7 | −4.8 ± 2.5 | −1.0 ± 27.1 | 2.3 ± 32.8 | 0.77 | 0.71 | 0.54 |
Late SusMagLR HR | −7.5 ± 28.6 | 27.1 ± 42.7 | −6.1 ± 34.9 | 7.2 ± 34.7 | <0.0001 | 0.066 | 0.11 |
Late SusMagLR TPR | 9.9 ± 69.8 | −25.7 ± 44.7 | −12.7 ± 61.8 | 14.4 ± 61.0 | 0.28 | 0.0036 | 0.37 |
Late SusMagLR SV | −13.3 ± 57.7 | −0.90 ± 22.5 | 12.4 ± 63.2 | −22.0 ± 53.1 | 0.31 | 0.021 | 0.67 |
Local minima of HR and TPR were ‘overt’ when their amplitude was lower than 3 SD below the mean of baseline for SBP, MAP, HR, and TPR and higher for SV. Massages were divided into four combinations of presence or absence of overt peaks for HR and TPR: ‘pure CI’ means overt HR and obscure TPR; ‘overt aVD’ means obscure HR and overt TPR; ‘both CI and aVD’ means overt HR and overt TPR; and ‘CI nor aVD’ means obscure HR and obscure TPR. Logratio values are shown after multiplication by 1000 to help appreciate their relative sizes. P-values represent ANOVA with the factor CI (present or absent) and aVD (present of absent) and their interaction.
Delta, difference between period of interest and baseline period; SusMagLR, sustained magnitude in logratio units.
aThis case represents a combination of HR and TPR decreases that were 2.5 and 2.6 SD away from the mean, so neither reached the threshold to be recognized as CI or aVD.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.